1. Okamoto, Y., Maehara, K., Yonezu, S., Mase, K., Yoshioka, M., Yasunaga, K. Laboratory and clinical studies on DL-8280. Chemotherapy 32 — Suppl. 1 (1984) 420–435.
2. Karch, F. E., Lasagna, L. Adverse drug reactions. A critical review. J. Am. Med. Ass. 2334 (1975) 1236–1339.
3. Karch, F. E., Lasagna, L. Toward the operational identification of adverse drug reactions. Clin. Pharm. Ther. 21 (1980) 247–251.
4. Maesen, F. P. V., Teengs, J. P., Baur, C., Davies, B. I. Quinolones and raised plasma concentrations of theophylline. Lancet II (1984) 530.
5. Corrado, M., Sabbaj, J., Brown, K., Struble, W., Cyhan, G.: The safety profile of norfloxacin (MKO366) during clinical trials. In:Dierich, M. P., Ronald, A., Shah, P. M. (eds.): Norfloxacin. Proceedings, 13th International Congress of Chemotherapy, Vienna 1983 ss 4.6 pp 9–12.